Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10451/23254 |
Resumo: | © The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. |
id |
RCAP_bb46c8409c945d6efa0a4df26d77d310 |
---|---|
oai_identifier_str |
oai:repositorio.ul.pt:10451/23254 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposureHIV-1Cholesterol-taggingDrug designBlood cells© The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.Objectives: The aim of the present work was to evaluate the interaction of two new HIV fusion inhibitors {HIVP3 [C34–polyethylene glycol (PEG)4–cholesterol] and HIVP4 [(C34–PEG4)2–cholesterol]} with membrane model systems and human blood cells in order to clarify where and how the fusion inhibitors locate, allowing us to understand their mechanism of action at the molecular level, and which strategies may be followed to increase efficacy. Methods: Lipid vesicles with defined compositions were used for peptide partition and localization studies, based on the intrinsic fluorescence of HIVP3 and HIVP4. Lipid monolayers were employed in surface pressure studies. Finally, human erythrocytes and peripheral blood mononuclear cells (PBMCs) isolated from blood samples were used in dipole potential assays. Results: Membrane partition, dipole potential and surface pressure assays indicate that the new fusion inhibitors interact preferentially with cholesterol-rich liquid-ordered membranes, mimicking biological membrane microdomains known as lipid rafts. HIVP3 and HIVP4 are able to interact with human erythrocytes and PBMCs to a similar degree as a previously described simpler drug with monomeric C34 and lacking the PEG spacer, C34–cholesterol. However, the pocket-binding domain (PBD) of both HIVP3 and HIVP4 is more exposed to the aqueous environment than in C34–cholesterol. Conclusions: The present data allow us to conclude that more efficient blocking of HIV entry results from the synergism between the membranotropic behaviour and the enhanced exposure of the PBD.This work was partially supported by Fundação para a Ciência e a Tecnologia—Ministério do Ensino e da Ciência (FCT-MEC, Portugal) projects PTDC/QUI-BIQ/104787/2008 and DELIN-HIVERA/0002-2013, and by National Institutes of Health (NIH, USA) project #R21NS076385 (to M. P.). A. H. also acknowledges FCT-MEC fellowship SFRH/BPD/72037/2010Oxford University PressRepositório da Universidade de LisboaAugusto, Marcelo T.Hollmann, AxelCastanho, Miguel A. R. B.Porotto, MatteoPessi, AntonelloSantos, Nuno C.2016-04-05T16:01:16Z20142014-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/23254engJ Antimicrob Chemother 2014; 69: 1286 –12970305-7453doi:10.1093/jac/dkt529info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:11:13Zoai:repositorio.ul.pt:10451/23254Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:40:41.606442Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure |
title |
Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure |
spellingShingle |
Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure Augusto, Marcelo T. HIV-1 Cholesterol-tagging Drug design Blood cells |
title_short |
Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure |
title_full |
Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure |
title_fullStr |
Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure |
title_full_unstemmed |
Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure |
title_sort |
Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure |
author |
Augusto, Marcelo T. |
author_facet |
Augusto, Marcelo T. Hollmann, Axel Castanho, Miguel A. R. B. Porotto, Matteo Pessi, Antonello Santos, Nuno C. |
author_role |
author |
author2 |
Hollmann, Axel Castanho, Miguel A. R. B. Porotto, Matteo Pessi, Antonello Santos, Nuno C. |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
Repositório da Universidade de Lisboa |
dc.contributor.author.fl_str_mv |
Augusto, Marcelo T. Hollmann, Axel Castanho, Miguel A. R. B. Porotto, Matteo Pessi, Antonello Santos, Nuno C. |
dc.subject.por.fl_str_mv |
HIV-1 Cholesterol-tagging Drug design Blood cells |
topic |
HIV-1 Cholesterol-tagging Drug design Blood cells |
description |
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014 2014-01-01T00:00:00Z 2016-04-05T16:01:16Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10451/23254 |
url |
http://hdl.handle.net/10451/23254 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
J Antimicrob Chemother 2014; 69: 1286 –1297 0305-7453 doi:10.1093/jac/dkt529 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Oxford University Press |
publisher.none.fl_str_mv |
Oxford University Press |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134317077594112 |